### Patient Information
This case series included 33 patients ranging in age from children to elderly adults (mean age 40 ± 27 years), all presenting with incomitant hypertropia—a vertical misalignment of the eyes that varies with gaze direction. The majority (20 patients) had superior oblique palsy, a common cause of incomitant hypertropia characterized by weakness or paralysis of the superior oblique muscle leading to overaction of the inferior oblique muscle. Patients were treated between June 2015 and June 2025 by a single surgeon.
### Diagnosis
Patients exhibited variable incomitant hypertropia documented in primary (central) gaze and secondary gazes at distance and near fixation. The diagnosis of incomitant hypertropia was established clinically by measuring the angle of vertical deviation using prism cover testing across multiple gaze positions. Superior oblique palsy was diagnosed based on clinical features including head posture, motility examination, and presence of overaction of the inferior oblique muscle.
### Differential Diagnosis
Other conditions potentially causing vertical strabismus or hypertropia were considered and ruled out based on clinical and imaging data when available. These included:
– Fourth nerve (trochlear) palsy due to trauma or ischemia
– Thyroid eye disease with restrictive myopathy
– Myasthenia gravis causing variable ocular misalignment
– Congenital cranial dysinnervation syndromes
– Restrictive strabismus from orbital fractures or scarring
Superior oblique palsy remained the predominant etiology based on consistent clinical signs and exclusion of other causes.
### Treatment and Management
All patients underwent a standardized unilateral inferior oblique muscle (IO) recession procedure performed by the same surgeon to ensure consistency. The surgical technique involved reattachment of the IO muscle 4 mm posterior and 3 mm temporal to the temporal border of the inferior rectus insertion. This “fixed-dose” approach applied the same recession amount regardless of initial hypertropia magnitude.
Pre- and postoperative hypertropia measurements were taken in central gaze and secondary gazes both at distance and near, assessing the degree of incomitance and vertical deviation.
The decision for unilateral surgery was guided by the clinical presentation, and additional strabismus intervention was reserved for patients with residual or recurrent deviation.
### Outcome and Prognosis
The mean follow-up period was 448 ± 562 days, allowing for assessment of both short-term and longer-term outcomes. Key findings included:
– A significant reduction in mean central gaze hypertropia from 8.8 ± 7.9 prism diopters (Δ) preoperatively to 1.2 ± 2.9Δ postoperatively.
– Contralateral gaze hypertropia diminished from 17.0 ± 9.6Δ to 2.1 ± 3.6Δ.
– Horizontal incomitance decreased from 13.7 ± 8.4Δ to 2.4 ± 4.1Δ.
– Vertical incomitance improved from 6.8 Δ to 2.0 ± 4.4Δ.
Notably, the surgical effect was proportionally greater in patients with larger preoperative deviations. This resulted in an almost ideal correction of hypertropia across all gaze positions and distances, effectively reducing incomitance.
Only 3 patients (9%) required additional strabismus treatment, indicating a high efficacy and durability of the fixed-dose IO recession approach.
### Discussion
This case series demonstrates that a fixed-dose unilateral inferior oblique recession offers a reliable and self-adjusting surgical correction for a wide range of incomitant hypertropia, particularly associated with superior oblique palsy. Key points include:
– **Self-Grading Effect:** Larger initial hypertropias experienced greater correction, suggesting the recession’s effect scales with muscle overaction severity.
– **Reduction of Incomitance:** By decreasing vertical and horizontal incomitance, the fixed-dose procedure improved binocular function in multiple gaze positions, enhancing patient quality of life.
– **Surgical Simplicity and Consistency:** A uniform recession technique simplifies surgical planning and training while providing predictable outcomes.
– **Low Reoperation Rate:** The 9% retreatment rate attests to the procedure’s effectiveness in resolving vertical deviations without frequent additional interventions.
The findings align with earlier literature reporting the benefits of IO muscle weakening in superior oblique palsy and other forms of incomitant hypertropia but extend the understanding by showing a uniform dose can adaptively correct variable degrees of misalignment.
**Educational Takeaway:** For clinicians managing patients with incomitant hypertropia, especially due to superior oblique palsy, adopting a fixed-dose inferior oblique recession approach may optimize surgical outcomes and reduce variability associated with titrating recession amounts.
### References
1. Nunziata S, Yehezkeli V, Neimark E, Demer JL. Fixed Dose Inferior Oblique Recession Has Self-Adjusting Effect. American Journal of Ophthalmology. 2026 Nov 7. PMID: 42998693.
2. Guyton DL. Superior oblique muscle palsy: diagnosis and management. J Pediatr Ophthalmol Strabismus. 2000.
3. Kushner BJ. Surgical management of superior oblique palsy. Curr Opin Ophthalmol. 2002.
4. Wright KW. Management of strabismus associated with oblique muscle dysfunction. Curr Opin Ophthalmol. 1996.
Specialty calculators
For clinical reference; use professional judgment.
